US Patent Issued to Yangzhou University on Nov. 11 for "Hybridoma cell line secreting an ActA monoclonal antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,922, issued on Nov. 11, was assigned to Yangzhou University (Yangzhou, China).

"Hybridoma cell line secreting an ActA monoclonal antibody and use thereof" was invented by Xinan Jiao (Yangzhou, China), Yuelan Yin (Yangzhou, China), Mengdi Zhao (Yangzhou, China), Fanzeng Meng (Yangzhou, China), Xiang Chen (Yangzhou, China), Jinlin Huang (Yangzhou, China), Zhiming Pan (Yangzhou, China) and Dan Gu (Yangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A hybridoma cell line secreting an ActA monoclonal antibody and a use thereof. The hybridoma cell line was deposited on Jul. 8, 2021, at the China Center for Type Culture Collection (CCTCC) with t...